The differential functional coupling of phosphodiesterase 4 to human DP and EP2 prostanoid receptors stimulated with PGD2 or PGE2

被引:2
|
作者
Okura, Iori [1 ]
Hasuoka, Nanae [2 ,3 ]
Senoo, Kanaho [2 ,3 ]
Suganami, Akiko [4 ]
Fukushima, Keijo [2 ,3 ]
Regan, John W. [5 ]
Mashimo, Masato [6 ]
Murayama, Toshihiko [1 ]
Tamura, Yutaka [4 ]
Fujino, Hiromichi [2 ,3 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan
[2] Tokushima Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol Life Sci, Tokushima 7708505, Japan
[3] Tokushima Univ, Grad Sch Biomed Sci, Tokushima 7708505, Japan
[4] Chiba Univ, Grad Sch Med, Dept Bioinformat, Chiba 2608670, Japan
[5] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
[6] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Pharmacol Lab, Kyoto 6100311, Japan
关键词
Human DP receptors; Human EP2 receptors; PGD(2); PGE(2); PDE4; PROSTAGLANDIN RECEPTOR; ASSOCIATION; CLONING; GENE;
D O I
10.1007/s43440-021-00247-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Human DP and EP2 receptors are two of the most homologically related receptors coupling with G(alpha)s-protein, which stimulate adenylyl cyclase to produce cAMP. Indeed, both receptors are considered to be generated by tandem duplication. It has been reported that other highly homologous and closely related beta 1- and beta 2-adrenergic receptors interact distinctly with and differentially regulate cAMP-specific phosphodiesterase (PDE) 4 recruitment. Methods First, we focused on the cAMP degradation pathways of DP and EP2 receptors stimulated by prostaglandin (PG) D-2 or PGE(2) using HEK cells stably expressing either human DP receptors or EP2 receptors. Then, distances between ligands and amino acids of the receptors were evaluated by molecular dynamics (MD) analysis. Results We found that PGD(2)/EP2 receptors exerted a greater effect on PDE4 activity than PGE(2)/EP2 receptors. Moreover, by MD analysis, either the PGD(2) or EP2 receptor was moved and the distance was shortened between them. According to the results, DP receptors retain reactivity for PGE(2), but EP2 receptors may be activated only by PGE(2), at least in terms of cAMP formation, through the differential functional coupling of PDE4 probably with beta-arrestin. Conclusion Since DP receptors and EP2 receptors are considered to be duplicated genes, DP receptors may still be in a rapid evolutionary stage as a duplicated copy of EP2 receptors and have not yet sufficient selectivity for their cognate ligand, PGD(2).
引用
收藏
页码:946 / 953
页数:8
相关论文
共 50 条
  • [1] The differential functional coupling of phosphodiesterase 4 to human DP and EP2 prostanoid receptors stimulated with PGD2 or PGE2
    Iori Okura
    Nanae Hasuoka
    Kanaho Senoo
    Akiko Suganami
    Keijo Fukushima
    John W. Regan
    Masato Mashimo
    Toshihiko Murayama
    Yutaka Tamura
    Hiromichi Fujino
    Pharmacological Reports, 2021, 73 : 946 - 953
  • [2] Functional pharmacology of human prostanoid EP2 and EP4 receptors
    Wilson, RJ
    Rhodes, SA
    Wood, RL
    Shield, VJ
    Noel, LS
    Gray, DW
    Giles, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 501 (1-3) : 49 - 58
  • [3] Human EP2 prostanoid receptors exhibit more constraints to mutations than human DP prostanoid receptors
    Tanimoto, Jun
    Fujino, Hiromichi
    Takahashi, Hiroki
    Murayama, Toshihiko
    FEBS LETTERS, 2015, 589 (06) : 766 - 772
  • [4] PGE2 decreases reactivity of human platelets by activating EP2 and EP4
    Smith, James P.
    Haddad, Elias V.
    Downey, Jason D.
    Breyer, Richard M.
    Boutaud, Olivier
    THROMBOSIS RESEARCH, 2010, 126 (01) : E23 - E29
  • [5] Mapping analysis of mutated cDNA sequences in human DP and EP2 prostanoid receptors
    Tanimoto, Jun
    Fujino, Hiromichi
    Hisaka, Akihiro
    Takahashi, Hiroki
    Murayama, Toshihiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S214 - S214
  • [6] PGE2 May Decrease Airway Inflammation and Muscular Hyperplasia in Eosinophilic Bronchitis Patients through Prostanoid Receptors EP2 and EP4
    Sastre, B.
    Fernandez-Nieto, M.
    Lopez, E.
    Gamez, C.
    Aguado, E.
    Quirce, S.
    Sastre, J.
    Del Pozo, V.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB44 - AB44
  • [7] Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists
    Zhao, Zhong
    Araldi, Gian Luca
    Xiao, Yufang
    Reddy, Adulla P.
    Liao, Yihua
    Karra, Srinivasa
    Brugger, Nadia
    Fischer, David
    Palmer, Elizabeth
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (23) : 6572 - 6575
  • [8] Expression, localization, and signaling of PGE2 and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle
    Milne, SA
    Perchick, GB
    Boddy, SC
    Jabbour, HN
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (09): : 4453 - 4459
  • [9] Prostaglandin receptor Ep2 mediates PGE2 stimulated hypercalcemia in mice in vivo
    Li, XD
    Tomita, M
    Pilbeam, CC
    Breyer, RM
    Raisz, LG
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 67 (3-4): : 173 - 180
  • [10] PGE2 and PGF2α signalling via EP2, EP4, and FP receptors in the human amnion and chorion-decidua.
    Carr, NJ
    Leask, R
    Jabbour, HN
    Riley, SC
    BIOLOGY OF REPRODUCTION, 2004, : 208 - 208